Latest News
AstraZeneca PLC
- AstraZeneca says FDA approves drug for rare kidney disease in adults
- AstraZeneca Partners With Oracle to Refine Clinical Research With AI
- AstraZeneca and Oracle launch global AI collaboration to advance clinical trial optimisation and support better patient outcomes
- AstraZeneca inks $1.5B insitro deal for AI-enabled target discovery of liver, heart disease drugs
- AstraZeneca Strikes Up to $1.5 Billion AI Drug Discovery Deal With Insitro
- NIPER Raebareli, AstraZeneca India partner to expand clinical trial sites across India
- NIPER Raebareli and AstraZeneca India Partner to Strengthen Clinical Research Capabilities Across 25 Emerging Geographies
- NIPER Raebareli, AstraZeneca partner to strengthen 25 clinical trial sites beyond metros
- AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
- AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination
- AstraZeneca invests $2B in Summit, gaining ‘seat at the table’ for PD-1/VEGF drug push
- AstraZeneca announces strategic equity investment and clinical collaboration with Summit Therapeutics to advance leading ADC combination strategy in cancer
Headlines from the last 30 days, linking to the original publishers. See all market news →